Observational findings reveal valuable prognostic markers in metastatic renal cell carcinoma, suggesting ongoing relevance in treatment planning.
Several indices reflecting body composition, nutritional status, and systemic inflammation remain valuable prognostic markers in patients with mRCC receiving ICI-based first-line therapy.
No takes yet. Share an insight, caveat, or question.
Tsuchiya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: